CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Casi Pharmaceuticals Inc 's Tangible Leverage Ratio

CASI's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




CASI Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -30.42 % -31.81 % -27.65 % 5.81 % -5.43 %
Y / Y Total Liabilities Change 67.01 % 8.23 % 19.12 % 25.57 % 24.81 %
Tangible Leverage Ratio MRQ 0.87 0.52 0.49 0.42 0.36
Overall Ranking # # # # #
Seq. Tangible Equity Change -7.73 % -11.25 % -12.74 % -2.63 % -9.57 %
Seq. Total Liabilities Change 52.78 % -5.17 % 1.68 % 13.37 % -1 %



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 52.78%, Tangible Leverage Ratio detoriated to 0.87, above company's average Tangible Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry Casi Pharmaceuticals inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is CASI Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Casi Pharmaceuticals Inc 's Tangible Equity $ 52 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals Inc 's Total Liabilities $ 45 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography


Cumulative Casi Pharmaceuticals Inc 's Tangible Leverage Ratio

CASI's Tangible Leverage Ratio for the trailling 12 Months

CASI Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -30.42 % -31.81 % -27.65 % 5.81 % -5.43 %
Y / Y Total Liabilities TTM Growth 67.01 % 8.23 % 19.12 % 25.57 % 24.81 %
Tangible Leverage Ratio TTM 0.56 0.44 0.39 0.35 0.33
Total Ranking TTM # 1224 # 1137 # 1371 # 1266 # 880
Seq. Tangible Equity TTM Growth -7.73 % -11.25 % -12.74 % -2.63 % -9.57 %
Seq. Total Liabilities TTM Growth 52.78 % -5.17 % 1.68 % 13.37 % -1 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 52.78%, Tangible Leverage Ratio improved to 0.56, above Casi Pharmaceuticals Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 134 other companies have achieved lower Tangible Leverage Ratio than Casi Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 1224.

Explain Tangible Leverage Ratio?
What is CASI Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 135
Healthcare Sector # 538
Within the Market # 1224


TTM Tangible Leverage Ratio Statistics
High Average Low
0.79 0.41 0.05
(Sep 30 2022)   (Dec 31 2018)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Rubius Therapeutics Inc   2.34 $ 85.546  Millions$ 36.587  Millions
Alector Inc   2.31 $ 583.934  Millions$ 253.104  Millions
Precision Biosciences Inc  2.27 $ 187.353  Millions$ 82.411  Millions
Lucira Health Inc   2.07 $ 125.980  Millions$ 60.889  Millions
Adma Biologics Inc   1.96 $ 187.173  Millions$ 95.663  Millions
Adaptimmune Therapeutics Plc  1.94 $ 218.865  Millions$ 112.769  Millions
Lantheus Holdings Inc   1.81 $ 457.888  Millions$ 253.270  Millions
Applied Uv Inc   1.73 $ 7.725  Millions$ 4.469  Millions
Sanara Medtech Inc   1.69 $ 15.452  Millions$ 9.154  Millions
Zivo Bioscience Inc   1.68 $ 2.555  Millions$ 1.524  Millions
Codiak Biosciences Inc   1.54 $ 59.883  Millions$ 38.929  Millions
Meiragtx Holdings Plc  1.47 $ 178.742  Millions$ 121.377  Millions
Armata Pharmaceuticals Inc   1.42 $ 45.081  Millions$ 31.831  Millions
Curis Inc   1.41 $ 66.006  Millions$ 46.763  Millions
Bio techne Corp  1.34 $ 402.290  Millions$ 300.202  Millions
Sangamo Therapeutics Inc   1.25 $ 284.759  Millions$ 228.204  Millions
Biocardia Inc  1.24 $ 5.082  Millions$ 4.097  Millions
Educational Development Corporation  1.22 $ 57.088  Millions$ 46.624  Millions
Logicbio Therapeutics Inc   1.20 $ 18.816  Millions$ 15.739  Millions
Precipio inc   1.17 $ 4.976  Millions$ 4.249  Millions
Aspira Women s Health Inc   1.14 $ 12.691  Millions$ 11.178  Millions
X4 Pharmaceuticals Inc  1.13 $ 50.393  Millions$ 44.498  Millions
Isoplexis Corporation  1.13 $ 60.313  Millions$ 53.343  Millions
Pluri Inc   1.09 $ 29.260  Millions$ 26.901  Millions
Livento Group Inc   0.99 $ 22.118  Millions$ 22.440  Millions
Repligen Corp  0.98 $ 614.267  Millions$ 624.143  Millions
Chase Corporation  0.98 $ 238.751  Millions$ 244.008  Millions
Atara Biotherapeutics Inc   0.97 $ 181.203  Millions$ 187.113  Millions
Telesis Bio Inc   0.96 $ 34.834  Millions$ 36.411  Millions
Myriad Genetics Inc   0.96 $ 295.400  Millions$ 309.300  Millions

Date modified: 2022-11-16T03:23:24+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CDLX's Profile

Stock Price

CDLX's Financials

Business Description

Fundamentals

Charts & Quotes

CDLX's News

Suppliers

CDLX's Competitors

Customers & Markets

Economic Indicators

CDLX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071